These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Immunohistochemical differentiation of high-grade prostate carcinoma from urothelial carcinoma. Chuang AY; DeMarzo AM; Veltri RW; Sharma RB; Bieberich CJ; Epstein JI Am J Surg Pathol; 2007 Aug; 31(8):1246-55. PubMed ID: 17667550 [TBL] [Abstract][Full Text] [Related]
10. Is GATA3 expression maintained in regional metastases?: a study of paired primary and metastatic urothelial carcinomas. Zhao L; Antic T; Witten D; Paner GP; Taxy JB; Husain A; Gwin K; Mirza MK; Lingen MW; Tretiakova MS Am J Surg Pathol; 2013 Dec; 37(12):1876-81. PubMed ID: 24121175 [TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical profile of the penile urethra and differential expression of GATA3 in urothelial versus squamous cell carcinomas of the penile urethra. Chaux A; Han JS; Lee S; Gonzalez-Roibon N; Sharma R; Burnett AL; Cubilla AL; Netto GJ Hum Pathol; 2013 Dec; 44(12):2760-7. PubMed ID: 24134931 [TBL] [Abstract][Full Text] [Related]
12. Immunohistochemical analysis of uroplakins, urothelial specific proteins, in ovarian Brenner tumors, normal tissues, and benign and neoplastic lesions of the female genital tract. Ogawa K; Johansson SL; Cohen SM Am J Pathol; 1999 Oct; 155(4):1047-50. PubMed ID: 10514386 [TBL] [Abstract][Full Text] [Related]
13. Immunoprofile of ovarian tumors with putative transitional cell (urothelial) differentiation using novel urothelial markers: histogenetic and diagnostic implications. Logani S; Oliva E; Amin MB; Folpe AL; Cohen C; Young RH Am J Surg Pathol; 2003 Nov; 27(11):1434-41. PubMed ID: 14576476 [TBL] [Abstract][Full Text] [Related]
14. Brenner tumors but not transitional cell carcinomas of the ovary show urothelial differentiation: immunohistochemical staining of urothelial markers, including cytokeratins and uroplakins. Riedel I; Czernobilsky B; Lifschitz-Mercer B; Roth LM; Wu XR; Sun TT; Moll R Virchows Arch; 2001 Feb; 438(2):181-91. PubMed ID: 11253121 [TBL] [Abstract][Full Text] [Related]
15. Prognostic impact of p63 and p53 expression in upper urinary tract transitional cell carcinoma. Zigeuner R; Tsybrovskyy O; Ratschek M; Rehak P; Lipsky K; Langner C Urology; 2004 Jun; 63(6):1079-83. PubMed ID: 15183954 [TBL] [Abstract][Full Text] [Related]
16. The utility of p63, p40, and GATA-binding protein 3 immunohistochemistry in diagnosing micropapillary urothelial carcinoma. Lin X; Zhu B; Villa C; Zhong M; Kundu S; Rohan SM; Yang XJ Hum Pathol; 2014 Sep; 45(9):1824-9. PubMed ID: 24993315 [TBL] [Abstract][Full Text] [Related]
17. Histogenesis of clear cell adenocarcinoma in the urinary tract: evidence of urothelial origin. Sung MT; Zhang S; MacLennan GT; Lopez-Beltran A; Montironi R; Wang M; Tan PH; Cheng L Clin Cancer Res; 2008 Apr; 14(7):1947-55. PubMed ID: 18381932 [TBL] [Abstract][Full Text] [Related]
18. Differential diagnosis of bladder versus colorectal adenocarcinoma: keratin 7 and GATA3 positivity in nuclear ß-catenin-negative glandular tumours defines adenocarcinoma of the bladder. Broede A; Oll M; Maurer A; Siegert S; Stoerkel S; Golz R; Schwamborn K; Veeck J; Knuechel R; Gaisa NT; J Clin Pathol; 2016 Apr; 69(4):307-12. PubMed ID: 26463756 [TBL] [Abstract][Full Text] [Related]
19. Transitional cell tumors of the ovary: a compact group with a heterogeneous histological and immunophenotypical pattern. Ceauşu M; Terzea D; Georgescu A; Dobrea C; Mihai M; Iosif C; Vasilescu F; Ardeleanu C Rom J Morphol Embryol; 2008; 49(4):513-6. PubMed ID: 19050800 [TBL] [Abstract][Full Text] [Related]
20. GATA3 expression in sarcomatoid urothelial carcinoma of the bladder. Fatima N; Osunkoya AO Hum Pathol; 2014 Aug; 45(8):1625-9. PubMed ID: 24824028 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]